Hint mode is switched on Switch off

ADC Therapeutics, ordinary share
ADCT, CH0499880968

FIND, SAVE & TRACK INVESTMENTS WITH CBONDS WATCHLIST

With Cbonds Watchlist you can always stay updated on your investments to make conscious decisions!

Watchlist
You need to request access
Add a stock to WL
ADC Therapeutics, сountry — Switzerland
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in
API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
ADC Therapeutics SA operates as a clinical-stage oncology drug discovery and development company. The Company focuses on advancing highly potent and targeted antibody drug conjugates (ADCs) for the treatment of hematological cancers and solid tumors. ADC ...
ADC Therapeutics SA operates as a clinical-stage oncology drug discovery and development company. The Company focuses on advancing highly potent and targeted antibody drug conjugates (ADCs) for the treatment of hematological cancers and solid tumors. ADC Therapeutics serves customers in the United States, Switzerland, and the United Kingdom.
  • Issuer
  • Full borrower / issuer name
    ADC Therapeutics SA
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NYSE
  • Ticker
    ADCT
  • Placement
    15.05.2020
  • Lock up period
    180
  • Number of papers
    12,245,631
  • Volume of raised funds
    232.67 mln USD
  • Placement share
    17.77%
  • Final placement price
    19 USD
  • Price change since placement date
    -94.53%
  • By capitalization
    1,308.96 mln USD
Other placements of the issuer
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NYSE
  • Ticker
    ADCT
  • Placement
    25.09.2020
  • Lock up period
    180
  • Number of papers
    6,000,000
  • Volume of raised funds
    204 mln USD
  • Placement share
    7.82%
  • Final placement price
    34 USD
  • Price change since placement date
    -96.94%
  • By capitalization
    2,608.34 mln USD
Registration is required to get access.